Ken Kramer, PhD

Vilazodone Efficacy Across Somatic and Psychic Symptoms of Depression: A Pooled Analysis From 4 Randomized and Placebo-Controlled Studies

Background: Vilazodone (VLZ) is a serotonin reuptake inhibitor and 5-HT1A receptor partial agonist approved for the treatment of Major Depressive Disorder (MDD). Historically, MDD studies...

Larry Culpepper , MD;

Pratap Chokka , MD, FRACP;

Ken Kramer , PhD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Ken Kramer, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products